Skip to main content
Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.02
-0.05 (-0.41%)
At close: Mar 9, 2026, 4:00 PM EDT
12.26
+0.24 (2.00%)
After-hours: Mar 9, 2026, 5:23 PM EDT

Crescent Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024
Period Ending
 Dec '25 Dec '24
Cash & Equivalents
213.1934.77
Cash & Short-Term Investments
213.1934.77
Cash Growth
513.22%-
Receivables
18-
Prepaid Expenses
5.460.04
Total Current Assets
236.6634.8
Property, Plant & Equipment
2.32-
Other Long-Term Assets
1.320.81
Total Assets
240.2935.62
Accounts Payable
100.11
Accrued Expenses
16.489.45
Current Portion of Leases
0.44-
Current Unearned Revenue
4.16-
Other Current Liabilities
50.06
Total Current Liabilities
36.079.61
Long-Term Debt
-37.48
Long-Term Leases
1.21-
Total Liabilities
37.2847.1
Common Stock
0.030
Additional Paid-In Capital
370.792.39
Retained Earnings
-171.81-17.87
Total Common Equity
199.01-15.48
Shareholders' Equity
203.01-11.48
Total Liabilities & Equity
240.2935.62
Total Debt
1.6437.48
Net Cash (Debt)
211.55-2.72
Net Cash Per Share
17.61-3.54
Filing Date Shares Outstanding
33.217.05
Total Common Shares Outstanding
33.217.05
Working Capital
200.5825.19
Book Value Per Share
5.99-2.20
Tangible Book Value
199.01-15.48
Tangible Book Value Per Share
5.99-2.20
Source: S&P Capital IQ. Standard template. Financial Sources.